In PDA, carcinogenesis begins with a gain‐of‐function mutation of KRAS in the pancreatic ductal epithelial cells, leading to the formation of pancreatic intraepithelial neoplasia (PanIN) lesions. Here, KRAS is linked to Patent ductus arteriosus.